From todays Q2 update Todays call was medium in length. A couple of Q & A.
Brought forward today, aside from the well known MBc & Pancreatic trial background.
1. since ASCO additional pharma companies have expressed business development interests with Onc.
2. There are still on- going CAR-T projects with pharmas/ Pela.
3. They have cashrunway near end if 2024.
4. Paperwork in in progress for Panc/ PanCan trial. The existing sites & protocols will ensure smooth progress once started.
5. Based on # 4 they are in talks with pharma for potential partners.
5a. They did say, we are in no rush & are working to create a competitive environment.
6. The recent offering was taken up by an institutional investor, specializing in the medical area.
7. The MBc trial? Bracelet is still showing progress. They did say still moving ahead, just not unrgency, due to some additional definitions of the requirements.
8 next big reveal would appear to be forthcoming october cancer conference.
being inclusive of goblet, panc & mbc
9. The CAR-t?
could be tomorrow or 20 years from now.
My cometary?
The most significant of all this , the $15mill buy- in of an institution.
They don't do that to loose. They think longer term.
The Nas does disclose institutional investors. Not sure about TSX ?
perhaps, some of our inquisitive minds can find out?
S.P.
apparently we are at a recent significantly higher short % than in a very long time,
GREAT!
next up- cycle , will not have any ATM , & shorts will need to cover.
Stay safe & healthy. Have a great week all.